229 related articles for article (PubMed ID: 29259714)
1. Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells.
Wuputra K; Lin CS; Tsai MH; Ku CC; Lin WH; Yang YH; Kuo KK; Yokoyama KK
Inflamm Regen; 2017; 37():15. PubMed ID: 29259714
[TBL] [Abstract][Full Text] [Related]
2. Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
Pan XY; Tsai MH; Wuputra K; Ku CC; Lin WH; Lin YC; Kishikawa S; Noguchi M; Saito S; Lin CS; Yokoyama KK
Anticancer Res; 2017 Jul; 37(7):3367-3377. PubMed ID: 28668824
[TBL] [Abstract][Full Text] [Related]
3. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.
Sarker DB; Xue Y; Mahmud F; Jocelyn JA; Sang QA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247819
[TBL] [Abstract][Full Text] [Related]
4. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
5. Method to Convert Stem Cells into Cancer Stem Cells.
Afify SM; Chen L; Yan T; Calle AS; Nair N; Murakami C; Zahra MH; Okada N; Iwasaki Y; Seno A; Seno M
Methods Protoc; 2019 Aug; 2(3):. PubMed ID: 31426391
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming strategies for the establishment of novel human cancer models.
Sancho-Martinez I; Izpisua Belmonte JC
Cell Cycle; 2016 Sep; 15(18):2393-7. PubMed ID: 27314153
[TBL] [Abstract][Full Text] [Related]
8. Translational models of 3-D organoids and cancer stem cells in gastric cancer research.
Wuputra K; Ku CC; Kato K; Wu DC; Saito S; Yokoyama KK
Stem Cell Res Ther; 2021 Sep; 12(1):492. PubMed ID: 34488885
[TBL] [Abstract][Full Text] [Related]
9. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
10. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
11. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
[TBL] [Abstract][Full Text] [Related]
12. Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation.
Afify SM; Seno M
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862050
[TBL] [Abstract][Full Text] [Related]
13. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
[TBL] [Abstract][Full Text] [Related]
14. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
Chao HM; Chern E
J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
[TBL] [Abstract][Full Text] [Related]
16. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells.
Liu H; Zhang W; Jia Y; Yu Q; Grau GE; Peng L; Ran Y; Yang Z; Deng H; Lou J
Cell Death Dis; 2013 Oct; 4(10):e857. PubMed ID: 24136221
[TBL] [Abstract][Full Text] [Related]
17. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
[TBL] [Abstract][Full Text] [Related]
18. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells.
Hsu HS; Liu CC; Lin JH; Hsu TW; Hsu JW; Li AF; Hung SC
J Biomed Sci; 2020 Jan; 27(1):5. PubMed ID: 31928533
[TBL] [Abstract][Full Text] [Related]
19. MBD3 inhibits formation of liver cancer stem cells.
Li R; He Q; Han S; Zhang M; Liu J; Su M; Wei S; Wang X; Shen L
Oncotarget; 2017 Jan; 8(4):6067-6078. PubMed ID: 27894081
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
